Objectives: The objective of this lecture is to understand the development of picosecond laser and to learn the use of picosecond laser in treating melasma. A brief review of melasma pathophysiology and clinical studies using picosecond laser in melasma will be discussed.
Introduction: Melasma is an acquired pigmentary disorder that occurs mainly in women of all racial and ethnic groups, but particularly affects those with Fitzpatrick skin types III–IV. It has a higher incidence in Asians, Hispanic and Mediterranean populations. It has exacerbations by pregnancy, oral contraceptives, UV exposure and thyroid diseases. The most common clinical presentation is mask-like hyperpigmentation of brow, mid cheek, upper lip and chin.
Materials / method: The picosecond laser is a laser device that uses a pulse duration of a trillionth of a second (10-12 sec) to target the chromophore. Picosecond lasers causes predominantly photoacoustic damage rather than photothermal destruction of pigment, thereby minimizes the post inflammatory side effects.
Results: The term laser toning originates from the improvements in skin tone that result from the use of the laser. This is commonly done in Southeast Asia to treat melasma and for brightening effect. It uses a large spot size (6-10mm), low fluence (< 1.6 J/cm2), QS/Pico 1064nm laser with a handpiece held perpendicular to the target with no clinical endpoint. The mechanism is believed to be subcellular selective photothermolysis. Some picosecond lasers have fractionated hand pieces that facilitate tissue remodelling and facial rejuvenation and are used to treat acne scarring, photoageing, and melasma.
Conclusion: The proper parameters to use in the treatment of Asian skin would also be emphasized in this lecture.
Declaraciones
¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No
¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No
¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No
¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No
Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.